Cargando…

Renal disease progression in autosomal dominant polycystic kidney disease

BACKGROUND: Autosomal dominant polycystic kidney disease is a lifelong progressive disorder. However, how age, blood pressure, and stage of chronic kidney disease (CKD) affect the rate of kidney function deterioration is not clearly understood. METHODS: In this long-term observational case study up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higashihara, Eiji, Horie, Shigeo, Muto, Satoru, Mochizuki, Toshio, Nishio, Saori, Nutahara, Kikuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416980/ https://www.ncbi.nlm.nih.gov/pubmed/22526483 http://dx.doi.org/10.1007/s10157-012-0611-9

Ejemplares similares

Kidney volume and function in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2013)

Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
por: Higashihara, Eiji, et al.
Publicado: (2014)

Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases
por: Higashihara, Eiji, et al.
Publicado: (2018)

Evidence-based clinical practice guidelines for polycystic kidney disease 2014
por: Horie, Shigeo, et al.
Publicado: (2016)

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Sekine, Akinari, et al.
Publicado: (2022)

Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System
por: Kinoshita, Moritoshi, et al.
Publicado: (2016)

PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease
por: Kimura, Tomoki, et al.
Publicado: (2023)

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial
por: Muto, Satoru, et al.
Publicado: (2017)

Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease
por: Horie, Shigeo, et al.
Publicado: (2021)

Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance
por: Mochizuki, Toshio, et al.
Publicado: (2021)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan
por: Muto, Satoru, et al.
Publicado: (2021)

Estimation of Changes in Kidney Volume Growth Rate in ADPKD
por: Higashihara, Eiji, et al.
Publicado: (2020)

Beneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney disease
por: Kugita, Masanori, et al.
Publicado: (2017)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease
por: Grantham, Jared J., et al.
Publicado: (2017)

Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients
por: Suzuki, Yasuo, et al.
Publicado: (2023)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Intraperitoneal rupture of renal cyst in autosomal dominant polycystic kidney disease
por: Hammami, Mohamed, et al.
Publicado: (2010)

Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Han, Miyeun, et al.
Publicado: (2014)

Unilateral renal displacement in an autosomal dominant polycystic kidney disease patient
por: Kim, Jin, et al.
Publicado: (2023)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease complicating renal ectopia and managed with renal transplantation
por: Connor, Andrew, et al.
Publicado: (2009)

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Monkeys mutant for PKD1 recapitulate human autosomal dominant polycystic kidney disease
por: Tsukiyama, Tomoyuki, et al.
Publicado: (2019)

Native Nephrectomy in Renal Transplant Recipients With Autosomal-Dominant Polycystic Kidney Disease
por: Chebib, Fouad T., et al.
Publicado: (2015)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Nephrotic syndrome and autosomal dominant polycystic kidney disease
por: Visciano, Bianca, et al.
Publicado: (2012)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease: updated perspectives
por: Rastogi, Anjay, et al.
Publicado: (2019)

Educational Case: Autosomal Dominant Polycystic Kidney Disease
por: Frazier, Ryan L., et al.
Publicado: (2020)

Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022)

Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
por: Casteleijn, Niek F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0stqa6avdr3qih15lnoat58b04